There is no denying the consolidation of companies in the pharma/bio industry. From 1996 to 2011 (16 years) there was approximately $776bn in M&A activity, while in the last eight years this amount has been exceeded in half the time ($892bn).
https://en.wikipedia.org/wiki/List_oOriginal Article
